Prevalencia en el hospital Teodoro Maldonado Carbo de artritis reumatoide y usos de tratamientos biológicos y no biológicos en el año 2016.

Abstract

Introduction: In our country, the most common inflammatory rheumatic disease is rheumatoid arthritis. This disease affects the economic, social and psychological parameters of the patient and the people around him. The cost of treatments is high, and people become less productive to generate money. Objective: Determinate the prevalence of patients with rheumatoid arthritis in the Rheumatology outpatient clinic of HTMC in the year 2016 and the treatment used. Materials and methods: An observational, descriptive and cross-sectional study was performed. It was decided to analyze the 1184 patients seen at the Rheumatology outpatient clinic of the HTMC in 2016, who meet the inclusion and exclusion criteria in the study. Results: 1184 patients were included, 1012 (85%) were female patients, and 172 (15%) were male patients. Sixty percent of the patients went 4 or more times a year to the rheumatology clinic. 1157 patients were prescribed conventional DMRDS, 326 biological DMARDS, 14 synthetic DMARDS. Conclusions: Rheumatoid arthritis was more prevalent in females, also was more prevalent in ages between 50 and 75 years regardless of gender. The most commonly used drugs were the conventional DMARDS, among them most prevalent was metrotexate. The biological DMARD that was most used was etanercept.